Date Filer Title Filing Type Shares Traded Price Total Held
September 20, 2018 Director Form 4 Open market or private purchase of non-derivative or derivative security 2,500 $2.70 14,750
November 19, 2008 Director Form 4 Open market or private purchase of non-derivative or derivative security 2,100 $2.70 122,562
September 20, 2012 Director Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 35,000 $2.72 296,025
September 20, 2012 Director Form 4 Exercise of in-the-money or at-the-money derivative security 35,000 $2.72 219,911
January 19, 2009 VP & Chief Medical Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 5,000 $2.72 19,000
January 19, 2009 VP & Chief Medical Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 11,667 $2.72 121,667
January 19, 2009 VP & Chief Medical Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 11,667 $2.72 133,334
January 19, 2009 VP & Chief Medical Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 11,666 $2.72 145,000
January 19, 2009 Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 8,334 $2.72 63,334
January 19, 2009 Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 8,333 $2.72 71,667
January 19, 2009 Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 8,333 $2.72 80,000
January 19, 2009 Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 11,667 $2.72 111,579
January 19, 2009 Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 11,667 $2.72 123,246
January 19, 2009 Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 11,666 $2.72 134,912
January 19, 2009 Chief Financial Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 6,667 $2.72 106,667
January 19, 2009 Chief Financial Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 6,667 $2.72 113,334
January 19, 2009 Chief Financial Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 6,666 $2.72 120,000
January 19, 2009 Chief Financial Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 5,000 $2.72 30,000
January 19, 2009 Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 8,334 $2.72 69,010
January 19, 2009 Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 8,333 $2.72 77,343
January 19, 2009 Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 8,333 $2.72 85,676
January 19, 2009 Director, President & CEO Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 25,000 $2.72 530,000
January 19, 2009 Director, President & CEO Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 25,000 $2.72 555,000
January 19, 2009 Director, President & CEO Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 25,000 $2.72 580,000
January 19, 2009 Director, President & CEO Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 8,333 $2.72 40,500

For recent transactions, including derivative transactions, see our Section 16 SEC filings page.

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.